Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma
Background. Survivin is an inhibitor of apoptosis protein involved in the regulation of cell proliferation that could be used as a marker for cancer diagnosis or prognosis. Our aim was to evaluate whether serum survivin levels influence the outcome of cisplatin-based chemotherapy in patients with ma...
Main Authors: | Katja Goričar, Viljem Kovač, Alenka Franko, Metoda Dodič-Fikfak, Vita Dolžan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2015/316739 |
Similar Items
-
The influence of genetic variability on the risk of developing malignant mesothelioma
by: Franko Alenka, et al.
Published: (2018-01-01) -
Soluble Mesothelin-Related Peptides Levels in Patients with Malignant Mesothelioma
by: Alenka Franko, et al.
Published: (2012-01-01) -
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
by: Kovac Viljem, et al.
Published: (2015-09-01) -
NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases
by: Franko Alenka, et al.
Published: (2020-01-01) -
The role of polymorphisms in glutathione-related genes in asbestos-related diseases
by: Franko Alenka, et al.
Published: (2021-01-01)